Cardlytics Inc
$ 0.60
-1.92%
05 Jun - close price
- Market Cap 3,475,400 USD
- Current Price $ 0.60
- High / Low $ 0.62 / 0.55
- Stock P/E N/A
- Book Value -0.07
- EPS -20.00
- Next Earning Report 2026-08-05
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.08 %
- ROE -3.56 %
- 52 Week High 3.28
- 52 Week Low 0.55
About
Cardlytics, Inc. operates an advertising platform within financial institutions' digital channels including online, mobile, email, and various real-time notifications in the United States and the United Kingdom. The company is headquartered in Atlanta, Georgia.
Analyst Target Price
$1.07
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-07 | 2026-03-04 | 2025-11-05 | 2025-08-06 | 2025-05-07 | 2025-03-12 | 2024-11-06 | 2024-08-07 | 2024-05-08 | 2024-03-14 | 2023-11-08 | 2023-08-01 |
| Reported EPS | -0.08 | 0.03 | -1.36 | -0.13 | -0.21 | -0.31 | -0.15 | -0.15 | -0.09 | 0.14 | 0.01 | -0.24 |
| Estimated EPS | -0.37 | -0.2767 | -0.33 | -0.16 | -0.27 | -0.47 | -0.27 | -0.2 | -0.11 | 0.12 | -0.01 | -0.43 |
| Surprise | 0.29 | 0.3067 | -1.03 | 0.03 | 0.06 | 0.16 | 0.12 | 0.05 | 0.02 | 0.02 | 0.02 | 0.19 |
| Surprise Percentage | 78.3784% | 110.8421% | -312.1212% | 18.75% | 22.2222% | 34.0426% | 44.4444% | 25% | 18.1818% | 16.6667% | 200% | 44.186% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-05 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | -0.11 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: CDLX
2026-06-03 20:11:22
Cardlytics, Inc. (CDLX) received a notice from Nasdaq on June 3, 2026, for failing to maintain a minimum bid price of $1.00 for 30 consecutive business days, thus breaching Listing Rule 5550(a)(2). The company has until November 30, 2026, to regain compliance and may consider a reverse stock split. This disclosure has no immediate impact on its listing status.
2026-06-03 20:11:22
Cardlytics (NASDAQ: CDLX) has received a notice from Nasdaq due to its common stock trading below $1.00 for 30 consecutive business days, risking delisting. To address this deficiency and modify its capital structure, the company has enacted a 1-for-10 reverse stock split and reduced its authorized common shares, effective June 5, 2026. The stock will begin trading on a split-adjusted basis on June 8, 2026, aiming to regain compliance with Nasdaq's minimum bid price requirement.
2026-05-22 05:40:30
Cardlytics (NASDAQ: CDLX) director Srishti A. Gupta reported routine equity compensation activity, exercising 11,000 restricted stock units (RSUs) to acquire 11,000 common shares and subsequently receiving a new grant of 11,000 RSUs. Following these transactions on May 20, 2026, her direct holdings of common stock increased to 17,148 shares. The newly granted RSUs are set to vest in full on the one-year anniversary of the grant, contingent on her continued role as a director.
2026-05-22 05:08:59
Andre J. Fernandez, a director at Cardlytics, Inc. (CDLX), increased his equity-based holdings through a routine compensation activity. He exercised 11,000 restricted stock units (RSUs) which vested after one year and received a new grant of 11,000 RSUs, contingent on his continued service as a director. Following these transactions, Fernandez directly owns 26,310 shares of Cardlytics common stock.
2026-05-21 20:39:20
Cardlytics director Scott A. Hill has increased his equity in the company through compensation-related transactions. He exercised 11,000 restricted stock units (RSUs) into common stock and received a new grant of 11,000 RSUs, which will vest after one year of board service. Following these transactions, Hill directly holds 68,748 shares of common stock and 11,000 outstanding RSUs.
2026-05-21 20:39:20
Cardlytics director Liane Hornsey reported an 11,000-share RSU vest, converting them into common stock, and received a new grant of 11,000 Restricted Stock Units (RSUs). Following these transactions, she directly holds 33,326 common shares and has the new 11,000 RSUs which will vest in one year provided she remains a director. These were routine equity compensation activities and not open-market trades.
